Paul Varki

SVP, GC & Chief Compliance Off, Zyla Life Sciences.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 10, 2026Shares withheld for tax 1,081 shares at $13.10 of Avalo Therapeutics, Inc.²
May 21, 2026Granted 24,300 shares of Avalo Therapeutics, Inc.³
May 6, 2026Sold 400 shares at $23.71 of Avalo Therapeutics, Inc.⁴
May 6, 2026Sold 9,253 shares at $22.70 of Avalo Therapeutics, Inc.⁴
May 6, 2026Sold 22,839 shares at $21.22 of Avalo Therapeutics, Inc.⁴
May 6, 2026Sold 5,196 shares at $19.78 of Avalo Therapeutics, Inc.⁴
May 6, 2026Sold 37,375 shares at $18.91 of Avalo Therapeutics, Inc.⁴
May 6, 2026Exercised options 12,563 shares at $8.04 of Avalo Therapeutics, Inc.⁴
May 6, 2026Exercised options 62,500 shares at $13.43 of Avalo Therapeutics, Inc.⁴
Dec 10, 2025Shares withheld for tax 1,016 shares at $4.10 of Avalo Therapeutics, Inc.⁵

The numbers on this page point here. Each one links to the record it came from.